Showing results (241-250 of 296) with videos related to

Sort By:
Pageof 30
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2017
CD8<sup>+</sup>CD28<sup>-</sup>CD127<sup>lo</sup>CD39<sup>+</sup> regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?Daniela Fenoglio, Chiara Dentone, Alessio Signori, et al.
Expert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
EJNMMI Research|July 9, 2020
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosisCecilia Marini, Vanessa Cossu, Tiziana Bonifacino, et al.
Bone Marrow Transplantation|September 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working partyRaffaella Greco, Riccardo Saccardi, Marta Ponzano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose CyclophosphamideAnna Maria Raiola, Antonio Risitano, Nicoletta Sacchi, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Journal of the Peripheral Nervous System : JPNS|June 5, 2026
A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin AmyloidosisMehrnaz Hamedani, Valeria Prada, Sara Massucco, et al.
Multiple Sclerosis and Related Disorders|October 15, 2019
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disordersGiovanni Novi, Francesca Bovis, Marco Capobianco, et al.
Clinical & Experimental Metastasis|February 16, 2024
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinationsMichele Maffezzoli, Matteo Santoni, Giulia Mazzaschi, et al.
Pageof 30